InventisBio Co Ltd (688382)

Shanghai
Currency in CNY
36.65
+5.60(+18.04%)
Closed·
688382 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
31.3036.78
52 wk Range
6.6737.39
Key Statistics
Edit
Bid/Ask
31.05 / 31.15
Prev. Close
31.05
Open
31.3
Day's Range
31.3-36.78
52 wk Range
6.67-37.39
Volume
31.42M
Average Volume (3m)
12.37M
1-Year Change
362.05%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688382 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
28.50
Downside
-22.24%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

InventisBio Co Ltd Company Profile

InventisBio Co., Limited, a clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States. The company’s drug candidates for the oncology therapeutic area include BPI-D0316, which is in Phase III clinical trial for the non-small cell lung cancer (NSCLS) indications; D-0502, which is in Phase I clinical trial for the breast cancer indications; and D-1553, which in Phase I clinical trial for NSCLS, colorectal cancer indications. Its drug candidates for the metabolic therapeutic area is D-0120, a Phase I and II clinical trial product for hyperuricemia and gout indications. The company has a collaboration agreement with Betta Pharmaceuticals. InventisBio Co., Limited was founded in 2013 and is headquartered in Pudong, China.

Employees
185
Market
China

Compare 688382 to Peers and Sector

Metrics to compare
688382
Peers
Sector
Relationship
P/E Ratio
−83.7x−17.6x−0.5x
PEG Ratio
−6.310.230.00
Price/Book
10.1x6.0x2.6x
Price / LTM Sales
106.7x15.5x3.1x
Upside (Analyst Target)
−8.2%12.1%45.7%
Fair Value Upside
Unlock−12.0%5.7%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 28.50
(-22.24% Downside)

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-0.10 / --
Revenue / Forecast
8.00M / --
EPS Revisions
Last 90 days

688382 Income Statement

FAQ

What Is the InventisBio (688382) Stock Price Today?

The InventisBio stock price today is 36.65

What Stock Exchange Does InventisBio Trade On?

InventisBio is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for InventisBio?

The stock symbol for InventisBio is "688382."

What Is the InventisBio Market Cap?

As of today, InventisBio market cap is 21.20B.

What Is InventisBio's Earnings Per Share (TTM)?

The InventisBio EPS (TTM) is -0.38.

When Is the Next InventisBio Earnings Date?

InventisBio will release its next earnings report on 22 Aug 2025.

From a Technical Analysis Perspective, Is 688382 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has InventisBio Stock Split?

InventisBio has split 0 times.

How Many Employees Does InventisBio Have?

InventisBio has 185 employees.

What is the current trading status of InventisBio (688382)?

As of 11 July 2025, InventisBio (688382) is trading at a price of 36.65, with a previous close of 31.05. The stock has fluctuated within a day range of 31.30 to 36.78, while its 52-week range spans from 6.67 to 37.39.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.